Therapy for Metastatic Urothelial Carcinoma | Erdafitnib, a Pan-FGFR Inhibitor

Arlene O. Seifker-Radtke, MD, University of Texas MD Anderson Cancer Center shares Therapy for Metastatic Urothelial Carcinoma | Erdafitnib, a Pan-FGFR Inhibitor at Annual Meeting 2018